Abstract
AbstractCombination of anti‐metastasis antagonists with cytotoxic agents has shown clinical activity, yet is constrained with unconditional activation and low tumor selectivity. Here, a chemokine receptor‐targeted metallo‐nanodrug is reported for in situ generated and hyperthermia‐enhanced oxidative stress and metastatic pathway blockade with tumor specificity to treat breast cancer metastasis. The self‐assembled metallo‐nanodrugs trigger reactive oxygen species (ROS) generation in situ with tumor stimuli, self‐amplify ROS level upon intrinsic photothermal heating, and accurately block chemokine receptor CXCR4 to suppress tumor cell anti‐apoptosis, migration, and invasion. CXCR4‐targeted metallo‐nanodrugs plus laser irradiation induced complete inhibition of tumor growth in 80% of mice, and caused 92.8% reduction of the number of gross metastatic lung nodules in murine breast carcinoma models. The present work provides an intelligent and bioactivatable platform for precision nanomedicine of metastatic breast cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
